For kvinder med kendt risiko for tromboemboliske tilstand, personlig eller familiehistorisk, kan behandling med gonadotropin øge risikoen.
In women with generally recognised risk factors for thrombo-embolic events, such as personal or family history, treatment with gonadotrophins may further increase the risk.